Resumo 6395: Desregulação metabólica como determinante do prognóstico e da resposta ao sorafenibe no câncer de fígado

Park et al. (Sex,) estudaram esta questão.

www.synapsesocial.com/papers/68e72e21b6db6435876a758d — DOI: https://doi.org/10.1158/1538-7445.am2024-6395

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Abstract 3063: Defining oncogene-specific metabolic vulnerabilities in a mouse model of hepatocellular carcinoma· 2024
2. Multi-omics of sorafenib responsiveness in HCC patients· 2025 · 2 citations
3. Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics· 2026
4. Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells· 2026
5. Abstract 6286: Metabolic abnormalities are early predictors of liver metastasis in patients with ER+ breast tumors· 2024